tesaglitazar has been researched along with Hyperglycemia, Postprandial in 2 studies
*Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henke, BR | 1 |
| Birketvedt, GS; Fagerberg, B; Gause-Nilsson, I; Ohman, KP; Schuster, H; Tonstad, S | 1 |
1 review(s) available for tesaglitazar and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2004 |
1 trial(s) available for tesaglitazar and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Improvement of postprandial lipid handling and glucose tolerance in a non-diabetic population by the dual PPARalpha/gamma agonist, tesaglitazar.
Topics: Adult; Alkanesulfonates; Blood Glucose; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin Resistance; Lipids; Male; Middle Aged; Phenylpropionates; Postprandial Period; PPAR alpha; PPAR gamma; Triglycerides | 2007 |